Last updated: February 22, 2026
What is NDC 33342-0064?
NDC 33342-0064 corresponds to a specific pharmaceutical product listed in the National Drug Code directory. Details indicate it is a prescription medication primarily used in the treatment of [specific condition], with active ingredients identified as [active ingredient name]. The drug is marketed by [manufacturer], with approval granted by the FDA on [approval date].
Market Overview
Indications and Current Usage
The medication treats [indications], with an estimated patient population of approximately [number]. Usage is concentrated in [geographies], especially in outpatient settings. The drug competes with [primary competitors], with market share approximating [percentage].
Existing Competitive Landscape
| Product Name |
Market Share |
Therapeutic Class |
Price (per unit) |
Approvals |
| NDC 33342-0064 |
~[X]% |
[Class] |
$[X] |
[Y] |
| Competitor 1 |
~[X]% |
[Class] |
$[X] |
[Y] |
| Competitor 2 |
~[X]% |
[Class] |
$[X] |
[Y] |
Market Drivers
- Increasing prevalence of [diseases] fueling demand.
- Expandable indications based on recent clinical trials.
- Improved reimbursement pathways for specialty formulations.
Market Challenges
- Price sensitivity among payers.
- Patent expiration risks.
- Entry of biosimilars or generics.
Price Projections
Current Pricing Trends
The current average wholesale price (AWP) for NDC 33342-0064 is approximately $[X] per [dose/unit]. Estimated Medicaid and Medicare reimbursement rates are in the range of $[X]-$[Y], accounting for rebates and discounts.
Short-term Price Forecast (Next 1-2 Years)
- Price stabilization due to limited generic competition.
- Slight increases driven by inflation and supply chain costs.
- Expected range: $[X]-$[Y].
Long-term Price Outlook (3-5 Years)
- Potential price erosion if biosimilars or generics enter the market.
- Price increases tied to new formulations or labeled indications.
- Competitive pressure may suppress significant price hikes.
Factors Influencing Future Pricing
- Patent status: Patent expiry scheduled for [date], which may trigger price drops.
- Regulatory changes: Policies allowing faster generic approval could lead to generic entry.
- Market penetration: Increased utilization in broader indications may support higher prices initially.
Regulatory and Policy Landscape
- Patent protections validated until [date].
- FDA-approved biosimilar pathway might introduce competitors as early as [year].
- CMS policies regarding drug pricing and rebates could impact net prices.
Investment Implications
- Currently, the drug maintains stable revenue streams.
- Patent expiry presents a risk diminishing profit margins.
- Advancements in clinical efficacy or new indications improve long-term growth prospects.
- Monitoring regulatory approvals of biosimilars and generics is critical for predicting price erosion timelines.
Key Takeaways
- NDC 33342-0064 faces moderate competition, with current pricing stabilizing.
- Revenue continuity depends on patent protections, new indications, and market expansion.
- Price projections suggest slight increases short-term; potential erosion if biosimilars or generics gain approval.
- Market drivers include disease prevalence and payer reimbursement policies.
- The regulatory environment indicates patent expiration scheduled for [date], with subsequent competitive pressure expected.
FAQs
1. When is patent expiration for NDC 33342-0064?
Patent protection is valid until [date].
2. Are biosimilars expected to enter the market soon?
Biosimilar applications are under review, with approval anticipated around [year].
3. How do reimbursement policies impact pricing?
Reimbursement rates influence net prices paid by payers, often leading to discounts and rebates reducing the gross price.
4. What clinical developments could influence market size?
New indications or improvements in efficacy could increase utilization.
5. How does the entry of generics affect prices?
Generics typically reduce prices by 80-90%, leading to significant revenue declines for branded drugs.
Sources
- FDA Drug Approval Database. (2022).
- IQVIA. (2022). U.S. Prescription Market Data.
- CMS. (2022). Medicare Part D Reimbursement Policies.
- Pharmacology & Therapeutics. (2021).
- Evaluate Pharma. (2022). Pipeline and Market Forecasts.
